Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Paxil Patent Delistings Open Door For Generic Paroxetine Approvals

Jul 07 2003

• By The Pink Sheet

Related Content

Paxil Delisting: Will Appellate Case On FDA Patent Listing Role Be Moot?

Jul 07 2003

Apotex Paxil ANDA: Presence Of Hemihydrate Does Not Infringe GSK’s Patent

Mar 10 2003

GSK Switch Success: Paxil CR Has 31% Of New Scripts; Augmentin ES, 49%

Feb 17 2003

Paxil Authorized Generic: Par Gets Puerto Rico Now, States Later

Apr 21 2003

Purepac Gabapentin 180-Day Exclusivity Award “Reasonable,” Judge Says

May 05 2003

Paxil Late-Listed Patents Are Questionable For Orange Book Listing – FTC

Aug 05 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window